IL98574A - Pharmaceutical compositions for the treatment of anxiety comprising a piperidyl indole derivative and some such novel compounds - Google Patents
Pharmaceutical compositions for the treatment of anxiety comprising a piperidyl indole derivative and some such novel compoundsInfo
- Publication number
- IL98574A IL98574A IL9857491A IL9857491A IL98574A IL 98574 A IL98574 A IL 98574A IL 9857491 A IL9857491 A IL 9857491A IL 9857491 A IL9857491 A IL 9857491A IL 98574 A IL98574 A IL 98574A
- Authority
- IL
- Israel
- Prior art keywords
- hydrogen
- halogen
- group
- oxygen
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK152090A DK152090D0 (da) | 1990-06-22 | 1990-06-22 | Piperidylsubstituerede indolderivater |
| SG19795A SG19795G (en) | 1990-06-22 | 1995-02-07 | Piperidyl-substituted indoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL98574A0 IL98574A0 (en) | 1992-07-15 |
| IL98574A true IL98574A (en) | 1995-11-27 |
Family
ID=26065861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9857491A IL98574A (en) | 1990-06-22 | 1991-06-20 | Pharmaceutical compositions for the treatment of anxiety comprising a piperidyl indole derivative and some such novel compounds |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5439922A (ja) |
| EP (1) | EP0533824B1 (ja) |
| JP (1) | JP3332232B2 (ja) |
| AT (1) | ATE113838T1 (ja) |
| AU (1) | AU650464B2 (ja) |
| CA (1) | CA2085987C (ja) |
| DE (1) | DE69105135T2 (ja) |
| DK (2) | DK152090D0 (ja) |
| FI (1) | FI925801A (ja) |
| HK (1) | HK51395A (ja) |
| IE (1) | IE65421B1 (ja) |
| IL (1) | IL98574A (ja) |
| NO (1) | NO924949L (ja) |
| NZ (1) | NZ238655A (ja) |
| SG (1) | SG19795G (ja) |
| WO (1) | WO1992000070A1 (ja) |
| ZA (1) | ZA914747B (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
| DK148292D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Forbindelser |
| US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
| US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
| DK123493D0 (da) * | 1993-11-01 | 1993-11-01 | Lundbeck & Co As H | Compounds |
| DK139593D0 (da) * | 1993-12-16 | 1993-12-16 | Lundbeck & Co As H | Compounds |
| DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
| GB9523583D0 (en) * | 1995-11-17 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| DE19707628A1 (de) * | 1997-02-26 | 1998-08-27 | Merck Patent Gmbh | Oxazolidinone |
| US6489341B1 (en) * | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
| US20070212412A1 (en) * | 2005-09-08 | 2007-09-13 | H. Lundbeck A/S | Stable solid formulation of sertindole |
| TW200821296A (en) * | 2006-06-01 | 2008-05-16 | Lundbeck & Co As H | Use of sertindole for the preventive treatment of suicidal behaviour |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2258843B1 (ja) * | 1974-01-30 | 1977-09-09 | Roussel Uclaf | |
| US4208417A (en) * | 1978-06-29 | 1980-06-17 | Pharmindustrie | Indole derivatives and their use as anxiolytics |
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| US4997841A (en) * | 1987-08-13 | 1991-03-05 | Glaxo Group Limited | Indole derivatives |
| GB8819024D0 (en) * | 1988-08-10 | 1988-09-14 | Glaxo Group Ltd | Chemical compounds |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
-
1990
- 1990-06-22 DK DK152090A patent/DK152090D0/da not_active Application Discontinuation
-
1991
- 1991-06-20 ZA ZA914747A patent/ZA914747B/xx unknown
- 1991-06-20 IL IL9857491A patent/IL98574A/en not_active IP Right Cessation
- 1991-06-20 IE IE213791A patent/IE65421B1/en not_active IP Right Cessation
- 1991-06-21 AU AU80684/91A patent/AU650464B2/en not_active Ceased
- 1991-06-21 NZ NZ238655A patent/NZ238655A/en not_active IP Right Cessation
- 1991-06-21 DE DE69105135T patent/DE69105135T2/de not_active Expired - Fee Related
- 1991-06-21 DK DK91912147.5T patent/DK0533824T3/da active
- 1991-06-21 JP JP51105091A patent/JP3332232B2/ja not_active Expired - Fee Related
- 1991-06-21 EP EP91912147A patent/EP0533824B1/en not_active Expired - Lifetime
- 1991-06-21 CA CA002085987A patent/CA2085987C/en not_active Expired - Fee Related
- 1991-06-21 WO PCT/DK1991/000168 patent/WO1992000070A1/en active IP Right Grant
- 1991-06-21 AT AT91912147T patent/ATE113838T1/de not_active IP Right Cessation
-
1992
- 1992-12-17 US US07/999,482 patent/US5439922A/en not_active Expired - Lifetime
- 1992-12-21 NO NO92924949A patent/NO924949L/no unknown
- 1992-12-21 FI FI925801A patent/FI925801A/fi not_active Application Discontinuation
-
1995
- 1995-02-07 SG SG19795A patent/SG19795G/en unknown
- 1995-04-06 HK HK51395A patent/HK51395A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69105135D1 (de) | 1994-12-15 |
| ZA914747B (en) | 1992-03-25 |
| EP0533824B1 (en) | 1994-11-09 |
| FI925801A0 (fi) | 1992-12-21 |
| IL98574A0 (en) | 1992-07-15 |
| NZ238655A (en) | 1993-11-25 |
| NO924949L (no) | 1993-02-19 |
| DK152090D0 (da) | 1990-06-22 |
| NO924949D0 (no) | 1992-12-21 |
| CA2085987A1 (en) | 1991-12-23 |
| AU8068491A (en) | 1992-01-23 |
| CA2085987C (en) | 2000-08-22 |
| ATE113838T1 (de) | 1994-11-15 |
| JPH05509080A (ja) | 1993-12-16 |
| HK51395A (en) | 1995-04-13 |
| DK0533824T3 (da) | 1995-05-01 |
| DE69105135T2 (de) | 1995-03-23 |
| AU650464B2 (en) | 1994-06-23 |
| SG19795G (en) | 1995-08-18 |
| WO1992000070A1 (en) | 1992-01-09 |
| US5439922A (en) | 1995-08-08 |
| IE65421B1 (en) | 1995-10-18 |
| EP0533824A1 (en) | 1993-03-31 |
| JP3332232B2 (ja) | 2002-10-07 |
| FI925801A (fi) | 1992-12-21 |
| IE912137A1 (en) | 1992-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI90976B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten indolijohdannaisten ja niiden happoadditiosuolojen valmistamiseksi | |
| CA2085987C (en) | Piperidyl-substituted indoles | |
| JP3165181B2 (ja) | 新規の３−アリールインドールおよび３−アリールインダゾール誘導体 | |
| CA2105385C (en) | Treatment of cognitive disorders | |
| JPH09500611A (ja) | 新規ピペリジニルチオインドール誘導体、それらの調製方法および、特に鎮痛剤として有用な、それらを含有する医薬組成物 | |
| EP0575430B1 (en) | Preparation of a medicament for the treatment of addiction to drugs and substances of abuse | |
| WO1992015301A1 (en) | Treatment of hypertension and peripheral vascular diseases | |
| NO165837B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive indolderivater og syreaddisjonssalter derav. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |